Pharmaceutical Companies Hiring in Japan
60 companies with 1,434 open permanent roles in Japan, tracked daily from each company's own careers page.
- 60
- 1,434
- +125
Market Snapshot
Who Is Hiring
Loading openings
60 companies with 1,434 open permanent roles in Japan, tracked daily from each company's own careers page.
60 companies with 1,434 open permanent roles in Japan, tracked daily from each company's own careers page.
EPS Corporation posts the most Clinical Research roles here: 18 of 46 across 17 employers, ahead of PSI CRO (4).
40% of classified postings ask for daily spoken English or more, against 15% across all tracked postings.
Postings here state remote or hybrid work in 16% of cases, against 27% across all tracked postings.
Free to join. Set your terms, stay hidden, and hear only from roles that state them.
Among 278 roles added in the past 30 days by 58 employers tracked for at least 30 days, Medical Affairs is 13% of additions against 7% of the standing stock.
48 live postings have changed their advertised salary since tracking began, 15% of those stating pay.
119 roles were added in the past 14 days: AbbVie added 14 roles in Tokyo, Bristol Myers Squibb added 13 roles in Tokyo, while Merck KGaA added 9 roles in Tokyo.
Additions in the past 14 days from the 35 companies tracked for at least three weeks, so a newly added company cannot read as a hiring surge.
Daily total across the 51 companies tracked through the whole period. Companies added mid-period are excluded until the window catches up to them. As of October 3, 2026 · tracked daily since August 1, 2026
Pharmaceutical · 322 postings with comparable stated pay, from 14 employers
median ¥7,500,000 · 322 postings
¥5,400,000
Typical advertised range
¥10,000,000
Postings by Advertised Range
Under ¥4M
2
¥4M–5.9M
49
¥6M–7.9M
143
How hiring on this page compares with its wider market, on the same measures.
Compared with every employer in the directory (1,170 companies).
State a Japanese Level
Native/Fluent (Native or JLPT N1)
12%
Professional Working Proficiency (JLPT N2)
5%
No mention
83%
State an English Skill
Native/Fluent (TOEIC 945-990)
7%
Share of postings stating each term
University degree
21%
5-9 years of experience
21%
3-4 years of experience
19%
Management experience
12%
Master's degree
10%
Share of classified postings
No English requirement stated
27%
No English required
0%
Some English (reading, email, occasional meetings)
30%
Daily business English (speaking, presenting)
38%
Not determinable
5%
Counts on this page come from AirTA's own daily checks of each company's careers page. When a number cannot be measured reliably, it is hidden rather than estimated. Industry describes the company, not the individual role, so an employer with several businesses appears under each industry it operates in. Report a data issue.
| 経理財務部ファイナンスグループ FP&A担当者 | Shionogi |
| Fezolinetant MR/ 婦人科領域MR【勤務地：全国（初任地要相談）】 | Astellas Pharma |
| Care Ecosystem Activation Manager | Amgen |
| [Japan] Sr Director / Director, Head of Strategic Execution & Management | Santen |
| Senior Manager Medical Information, Japan | Revolution Medicines |
| Senior Manager, General Affairs & Workplace Operations | Revolution Medicines |
| Manager, Human Resources Operations, Japan | Revolution Medicines |
| Oncology MSL Manager, Japan Oncology Medical | GSK |
| Head, Disease Area, Japan Oncology Medical | GSK |
| Associate Director, Site Supply Chain | Bristol Myers Squibb |
| Associate Director, External Manufacturing Quality, Cell Therapy Global Quality | Bristol Myers Squibb |
| 治験薬サプライチェーン担当者 / Investigational Drug Supply Chain Specialist | Chugai Pharmaceutical |
| Customer Insights Manager | non-line manager | Strategic Planning and Execution Excellence Dept.,CXE | Boehringer Ingelheim |
| 【大阪｜問い合わせ対応・FAQ作成・データ分析・委託先管理担当】メディカルコニュニケーション部｜～ジェネリック医薬品のリーディングカンパニー | Sawai Pharmaceutical |
| Analyst,QualityControl | Johnson & Johnson |
| がん領域における新規創薬コンセプト創出・検証を担う薬理研究員 | Eisai |
| Lung Cancer Product Manager | Amgen |
| Associate Director, PDAC Marketing, Japan | Revolution Medicines |
| Senior Manager, PDAC Marketing, Japan | Revolution Medicines |
| Pipeline MSL（東日本） | GSK |
| Medical Oncology Head | Novartis |
¥8M–9.9M
66
¥10M–11.9M
47
¥12M–13.9M
14
¥14M–15.9M
1
| Roles closed per employer (30 days) | 1.9 | 2.2 |
| Median days a role stays open | Too few roles have closed yet to measure how long they stay open. | ||
| Postings stating a salary | 22% | 44% |
| Median advertised salary | ¥7,500,000 | ¥7,500,000 |
| Classified postings requiring English (E1 or above) | 71% | 35% |
| Classified postings needing daily English (E3 or above) | 40% | 15% |
| Management-level titles | 26% | 14% |
Counts are per-employer averages; shares are across all live postings on October 2, 2026. English rows use the English-level classification (a subset of postings), so they differ from the share of postings mentioning English in the Market Snapshot. A row is hidden when either side has too few postings to compare fairly.
Professional Working Proficiency (TOEIC 785-944)
19%
Limited Working Proficiency (TOEIC 550-784)
9%
Mentioned, level not specified
12%
No mention
53%
Parsed from 1,428 live postings with readable descriptions. A posting can state both languages.
10+ years of experience
6%
1-2 years of experience
6%
Same-industry experience
5%
Share of postings stating each term
Stakeholder Management
28%
Project Management
25%
Data Analysis
15%
Excel
14%
PowerPoint
8%
Share of classified postings
Industry switchers welcome
1%
Clinical background accepted
1%
Function switchers welcome
0%
Classified from the text of 1,288 of 1,434 active postings